Hermann Reichenspurner

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial

Philippe Menasché, Ottavio Alfieri, Stefan Janssens et al. · Circulation · 2008 · 938 citations

Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients

T. Deuse, Xiaomeng Hu, Alessia Gravina et al. · Nature Biotechnology · 2019 · 692 citations

Immune Rejection, Hypoimmunogenic Derivatives, Transplantation +11

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 618 citations · Full text

Percutaneous Coronary Intervention, Controlled Syntax Trial, Endovascular Technique +8

Concomitant Implantation of Impella® on Top of Veno-Arterial Extracorporeal Membrane Oxygenation May Improve Survival of Patients with Cardiogenic Shock

Federico Pappalardo, Christian Schulte, Marina Pieri et al. · European Journal of Heart Failure · 2016 · 505 citations · Full text

Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation

Benedikt Schrage, Peter Moritz Becher, A. Bernhardt et al. · Circulation · 2020 · 482 citations · Full text